Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Immunological Reviews
|
December 20, 2015
Age-associated B cells: key mediators of both protective and autoreactive humoral responses
Martin S Naradikian, Yi Hao, Michael P Cancro
Current Opinion in Immunology
|
April 4, 2015
BAFF receptors and ligands create independent homeostatic niches for B cell subsets
Martin S Naradikian, Alison R Perate, Michael P Cancro
Journal of Leukocyte Biology
|
March 15, 2020
Harnessing neoantigen specific CD4 T cells for cancer immunotherapy
Spencer E Brightman, Martin S Naradikian, Aaron M Miller, et al.
Experimental Gerontology
|
January 7, 2014
Memory B cells form in aged mice despite impaired affinity maturation and germinal center kinetics
Radhika Goenka, Jean L Scholz, Martin S Naradikian, et al.
Blood
|
May 13, 2011
A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice
Yi Hao, Patrick O'Neill, Martin S Naradikian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 31, 2015
B Cell-Intrinsic Expression of the HuR RNA-Binding Protein Is Required for the T Cell-Dependent Immune Response In Vivo
Amy DeMicco, Martin S Naradikian, Vishal J Sindhava, et al.
Cancer Research Communications
|
March 2, 2023
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity
Talar Tokatlian, Grace E Asuelime, Martin S Naradikian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 18, 2017
Age-Associated B Cells Express a Diverse Repertoire of V<sub>H</sub> and Vκ Genes with Somatic Hypermutation
Lisa M Russell Knode, Martin S Naradikian, Arpita Myles, et al.
Journal for Immunotherapy of Cancer
|
January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
Talar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
JCI Insight
|
December 13, 2022
Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells
Spencer E Brightman, Martin S Naradikian, Rukman R Thota, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Immunological Reviews
|
December 20, 2015
Age-associated B cells: key mediators of both protective and autoreactive humoral responses
Martin S Naradikian, Yi Hao, Michael P Cancro
Current Opinion in Immunology
|
April 4, 2015
BAFF receptors and ligands create independent homeostatic niches for B cell subsets
Martin S Naradikian, Alison R Perate, Michael P Cancro
Journal of Leukocyte Biology
|
March 15, 2020
Harnessing neoantigen specific CD4 T cells for cancer immunotherapy
Spencer E Brightman, Martin S Naradikian, Aaron M Miller, et al.
Experimental Gerontology
|
January 7, 2014
Memory B cells form in aged mice despite impaired affinity maturation and germinal center kinetics
Radhika Goenka, Jean L Scholz, Martin S Naradikian, et al.
Blood
|
May 13, 2011
A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice
Yi Hao, Patrick O'Neill, Martin S Naradikian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 31, 2015
B Cell-Intrinsic Expression of the HuR RNA-Binding Protein Is Required for the T Cell-Dependent Immune Response In Vivo
Amy DeMicco, Martin S Naradikian, Vishal J Sindhava, et al.
Cancer Research Communications
|
March 2, 2023
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity
Talar Tokatlian, Grace E Asuelime, Martin S Naradikian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 18, 2017
Age-Associated B Cells Express a Diverse Repertoire of V<sub>H</sub> and Vκ Genes with Somatic Hypermutation
Lisa M Russell Knode, Martin S Naradikian, Arpita Myles, et al.
Journal for Immunotherapy of Cancer
|
January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells
Talar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
JCI Insight
|
December 13, 2022
Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells
Spencer E Brightman, Martin S Naradikian, Rukman R Thota, et al.
Page
of 2